HMCN2
Hemicentin-2
Also known as: DKFZp434P0216, FLJ23816, HMCN2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8NDA2
- Gene
- HMCN2
- Ensembl
- ENSG00000148357
- Chromosome
- 9
- Canonical length
- 5079 aa
- Protein class
- Predicted intracellular proteins, Predicted secreted proteins
- Subcellular location
- Vesicles
- Secretome location
- Secreted to extracellular matrix
OverviewNCBI Gene
Predicted to enable axon guidance receptor activity. Predicted to be involved in homophilic cell adhesion via plasma membrane adhesion molecules and synapse organization. Located in collagen-containing extracellular matrix. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
5079 residues, UniProt reviewed canonical sequence.
>Q8NDA2|HMCN2
1 MMPGAPLLRL LTAVSAAVAV AVAGAPGTVM PPTTGDATLA FVFDVTGSMW DELMQVIDGA
61 SRILERSLSR RSQAIANYAL VPFHDPDIGP VTLTADPTVF QRELRELYVQ GGGDCPEMSV
121 GAIKAAVEVA NPGSFIYVFS DARAKDYHKK EELLRLLQLK QSQVVFVLTG DCGDRTHPGY
181 LAYEEIAATS SGQVFHLDKQ QVTEVLKWVE SAIQASKVHL LSTDHEEEGE HTWRLPFDPS
241 LKEVTISLSG PGPEIEVQDP LGRILQEDEG LNVLLNIPDS AKVVAFKPEH PGLWSIKVYS
301 SGRHSVRITG VSNIDFRAGF STQPLLDLNH TLEWPLQGVP ISLVINSTGL KAPGRLDSVE
361 LAQSSGKPLL TLPTKPLSNG STHQLWGGPP FHTPKERFYL KVKGKDHEGN PLLRVSGVSY
421 SGVAPGAPLV SMAPRIHGYL HQPLLVSCSV HSALPFRLQL RRGEARLGEE RHFQESGNSS
481 WEILRASKAE EGTYECTAVS RAGTGRAKAQ IVVTDPPPQL VPAPNVTVSP GETAVLSCRV
541 LGEAPYNLTW VRDWRVLPAS TGRVAQLADL SLEISGIIPT DGGRYQCVAS NANGVTRASV
601 WLLVREAPQV SIHTSSQHFS QGVEVKVSCS ASGYPTPHIS WSRESQALQE DSRIHVDAQG
661 TLIIQGVAPE DAGNYSCQAT NEVGTDQETV TLYYTDPPSV SAVNAVVLVA VGEEAVLVCE
721 ASGVPPPRVI WYRGGLEMIL APEGSSSGKL RIPAAQERDA GTYTCRAVNE LGDASAEIQL
781 AVGHAPQLTE LPRDVTVELG RSALLACRAT GRPPPTVTWR RGDGQPLGLR LGAGRGSRSR
841 QPDSGVLFFE SVAPEDQAPY VCEARNVFGK VQAEARLIVT GHAPPQIASS APTVRVLEGQ
901 PVSLPCIVLA GRPLPERHWL KDGRPLPPGS RHSIRADGSL HLDRALQEHA GRYSCVATNT
961 AGSQHRDVEL VVQVPPRIHP TATHHITNEG VAASLPCVAS GVPAPTITWT KETNALTSRG
1021 PHYNVSKEGT LLIAQPSAQD AGAYVCTATN TVGFSSQEMR LSVNTKPRIH MNGSRNADVP
1081 LQVTAKAGEE VTLDCEAKGS PPPLVTWTKD SRPVPPITNR YGLLPSGSLR LAQVQVGDSG
1141 HYECTASNPA GSASHRYVLG VQVPPQVQPG PRVLKVLVGE ALDLNCVAEG NPEPQLSWSK
1201 DGVVLQGRGP QGSVHFAAIR TSDAGRYRCE ASNSAGVDAW EVELRVLEPP HWGADETSGL
1261 LERVAGENAS LPCPARGTPK PQVTWRKGPS SEPLHGQPGV AVLEEGSLFL ASVSPADSGD
1321 YECQATNEVG STSRRAKLVV YVPPSIREDG RKANVSGMAG QSLTLECDAN GFPVPEIVWL
1381 KDAQLIPKVG GHRLLDEGQS LHFPRIQEGD SGLYSCRAEN QAGTAQRDFH LLVLTPPSVL
1441 GAGAAQEVLG LAGADVELQC WTSGVPTPQV EWTKDRQPVL PGGPHLQVQE DGQVLRITGS
1501 HVGDEGRYQC VAFSPAGQQA RDFQLRVHAP PTIWGSNETG EVAVMEDHLV QLLCEARGVP
1561 TPNITWFKDG ALLPTSTKVV YTRGGRQLQL GRAQSSDAGV YTCKASNAVG AAEKATRLDV
1621 YVPPTIEGAG GRPYVVKAVA GRPVALECVA RGHPSPTLSW HHEGLPVAES NESRLETDGS
1681 VLRLESPGEA SSGLYSCVAS SPAGEAVLQY SVEVQVPPQL LVAEGLGQVT TIVGQPLELP
1741 CQASGSPVPT IQWLQNGRPA EELAGVQVAS QGTTLHIDHV ELDHSGLFAC QATNEAGTAG
1801 AEVEVSVHEF PSVSIIGGEN ITAPFLQPVT LQCIGDGVPT PSLRWWKDGV ALAAFGGNLQ
1861 IEKVDLRDEG IYTCAATNLA GESKREVALK VLVPPNIEPG PVNKAVLENA SVTLECLASG
1921 VPPPDVSWFK GHQPVSSWMG VTVSVDGRVL RIEQAQLSDA GSYRCVASNV AGSTELRYGL
1981 RVNVPPRITL PPSLPGPVLV NTPVRLTCNA TGAPSPTLMW LKDGNPVSPA GTPGLQVFPG
2041 GRVLTLASAR ASDSGRYSCV AVSAVGEDRQ DVVLQVHMPP SILGEELNVS VVANESVALE
2101 CQSHAMPPPV LSWWKDGRPL EPRPGVHLSA DKALLQVDRA DVWDAGHYTC EALNQAGHSE
2161 KHYNLNVWVA PVFPLRESHT LTVREGHPTR LSCECRGVPF PKISWRKDGQ PLPGEGAGLQ
2221 HVSAVGRLLY LGQAQLAQEG TYTCECSNVV GNSSQDLQLE VHVPPQIAGP REPPTQVSVV
2281 QDGVATLECN ATGKPPPTVT WERDGQPVGA ELGLQLQNQG QSLHVERAQA AHTGRYSCVA
2341 ENLAGRAERK FELSVLVPPE LIGDLDPLTN ITAALHSPLT LLCEAMGIPP PAIRWFRGEE
2401 PVSPGEDTYL LAGGWMLKMT QTQEQDSGLY SCLASNEAGE ARRNFSVEVL VPPSIENEDL
2461 EEVIKVLDGQ TAHLMCNVTG HPQPKLTWFK DGRPLARGDA HHISPDGVLL QVLQANLSSA
2521 GHYSCIAANA VGEKTKHFQL SVLLAPTILG GAEDSADEEV TVTVNNPISL ICEALAFPSP
2581 NITWMKDGAP FEASRNIQLL PGTHGLQILN AQKEDAGQYT CVVTNELGEA VKNYHVEVLI
2641 PPSISKDDPL AEVGVKEVKT KVNSTLTLEC ESWAVPPPTI RWYKDGQPVT PSSRLQVLGE
2701 GRLLQIQPTQ VSDSGRYLCV ATNVAGEDDQ DFNVLIQVPP MFQKVGDFSA AFEILSREEE
2761 ARGGVTEYRE IVENNPAYLY CDTNAIPPPD LTWYREDQPL SAGDEVSVLQ GGRVLQIPLV
2821 RAENAGRYSC KASNEVGEDW LHYELLVLTP PVILGDTEEL VEEVTVNASS TVSLQCPALG
2881 NPVPTISWLQ NGLPFSPSPR LQVLEDGQVL QVSTAEVADA ASYMCVAENQ AGSAEKLFTL
2941 RVQVPPRIAG LDLEQVTAIL NSSVSLPCDV HAHPNPEVTW YKDSQALSLG EEVFLLPGTH
3001 TLQLGRARLS DSGMYTCEAL NAAGRDQKLV QLSVLVPPAF RQAPRGPQDA VLVRVGDKAV
3061 LSCETDALPE PTVTWYKDGQ PLVLAQRTQA LRGGQRLEIQ EAQVSDKGLY SCKVSNVAGE
3121 AVRTFTLTVQ VPPTFENPKT ETVSQVAGSP LVLTCDVSGV PAPTVTWLKD RMPVESSAVH
3181 GVVSRGGRLQ LSRLQPAQAG TYTCVAENTQ AEARKDFVVA VLVAPRIRSS GVAREHHVLE
3241 GQEVRLDCEA DGQPPPDVAW LKDGSPLGQD MGPHLRFYLD GGSLVLKGLR ASDAGAYTCV
3301 AHNPAGEDAR LHTVNVLVPP TIKQGADGSG TLVSRPGELV TMVCPVRGSP PIHVSWLKDG
3361 LPLPLSQRTL LHGSGHTLRI SKVQLADAGI FTCVAASPAG VADRNFTLQV QVPPVLEPVE
3421 FQNDVVVVRG SLVELPCEAR GVPLPLVSWM KDGEPLLSQS LEQGPSLQLE AVGAGDSGTY
3481 SCVAVSEAGE ARRHFQLTVM EPPHIEDSGQ PTELSLTPGA PMELLCDAQG TPQPNITWHK
3541 DGQALTRLEN NSRATRVLRV ENVQVRDAGL YTCLAESPAG AIEKSFRVRV QAPPNIVGPR
3601 GPRFVVGLAP GQLVLECSVE AEPAPKITWH RDGIVLQEDA HTQFPERGRF LQLQALSTAD
3661 SGDYSCTARN AAGSTSVAFR VEIHTVPTIR SGPPAVNVSV NQTALLPCQA DGVPAPLVSW
3721 RKDRVPLDPR SPRFEILPEG SLRIQPVLAQ DAGHYLCLAS NSAGSDRQGR DLRVLEPPAI
3781 APSPSNLTLT AHTPALLPCE ASGSPKPLVV WWKDGQKLDF RLQQGAYRLL PSNALLLTAP
3841 GPQDSAQFEC VVSNEVGEAH RLYQVTVHVP PTIADDQTDF TVTMMAPVVL TCHSTGIPAP
3901 TVSWSKAGAQ LGARGSGYRV SPSGALEIGQ ALPIHAGRYT CSARNSAGVA HKHVFLTVQA
3961 SPVVKPLPSV VRAVAEEEVL LPCEASGIPR PTITWQKEGL NVATGVSTQV LPGGQLRIAH
4021 ASPEDAGNYL CIAKNSAGSA MGKTRLVVQV PPVIENGLPD LSTTEGSHAF LPCKARGSPE
4081 PNITWDKDGQ PVSGAEGKFT IQPSGELLVK NLEGQDAGTY TCTAENAVGR ARRRVHLTIL
4141 VLPVFTTLPG DRSLRLGDRL WLRCAARGSP TPRIGWTVND RPVTEGVSEQ DGGSTLQRAA
4201 VSREDSGTYV CWAENRVGRT QAVSFVHVKE APVLQGEAFS YLVEPVGGSI QLDCVVRGDP
4261 VPDIHWIKDG LPLRGSHLRH QLQNGSLTIR RTERDDAGRY QCLAENEMGV AKKVVILVLQ
4321 SAPVFQVEPQ DMTVRSGDDV ALRCQATGEP TPTIEWLQAG QPLRASRRLR TLPDGSLWLE
4381 NVETGDAGTY DCVAHNLLGS ATARAFLVVR GEPQGSWGSM TGVINGRKFG VATLNTSVMQ
4441 EAHSGVSSIH SSIRHVPANV GPLMRVLVVT IAPIYWALAR ESGEALNGHS LTGGRFRQES
4501 HVEFATGELL TMTQVARGLD PDGLLLLDVV VNGVVPESLA DADLQVQDFE EHYVQTGPGQ
4561 LFVGSTQRFF QGGLPSFLRC NHSIQYNAAR GPQPQLVQHL RASAISSAFD PEAEALRFQL
4621 ATALQAEENE VGCPEGFELD SQGAFCVDRD ECSGGPSPCS HACLNAPGRF SCTCPTGFAL
4681 AWDDRNCRDV DECAWDAHLC REGQRCVNLL GSYRCLPDCG PGFRVADGAG CEDVDECLEG
4741 LDDCHYNQLC ENTPGGHRCS CPRGYRMQGP SLPCLDVNEC LQLPKACAYQ CHNLQGSYRC
4801 LCPPGQTLLR DGKACTSLER NGQNVTTVSH RGPLLPWLRP WASIPGTSYH AWVSLRPGPM
4861 ALSSVGRAWC PPGFIRQNGV CTDLDECRVR NLCQHACRNT EGSYQCLCPA GYRLLPSGKN
4921 CQDINECEEE SIECGPGQMC FNTRGSYQCV DTPCPATYRQ GPSPGTCFRR CSQDCGTGGP
4981 STLQYRLLPL PLGVRAHHDV ARLTAFSEVG VPANRTELSM LEPDPRSPFA LRPLRAGLGA
5041 VYTRRALTRA GLYRLTVRAA APRHQSVFVL LIAVSPYPYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against HMCN2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0
- Highest tissue expression
- 37 nTPM
Expression across tissuesHPA
Tissue
- colon: 37 nTPM
- skeletal muscle: 23 nTPM
- endometrium: 21 nTPM
- small intestine: 15 nTPM
- blood vessel: 14 nTPM
- heart muscle: 9.7 nTPM
Single-cell type
- myosatellite cells: 811 nCPM
- fibro-adipogenic progenitors: 521 nCPM
- early spermatids: 53 nCPM
- enterocytes: 41 nCPM
- smooth muscle cells: 38 nCPM
- late spermatids: 31 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- pons: 9.2 nTPM
- medulla oblongata: 4.5 nTPM
- spinal cord: 3 nTPM
- hypothalamus: 2.5 nTPM
- cerebral cortex: 1.8 nTPM
- midbrain: 1.8 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.01
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.07
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- EGF-type aspartate/asparagine hydroxylation site
- EGF-like domain
- EGF-like calcium-binding domain
- Immunoglobulin subtype 2
- Immunoglobulin domain subtype
- G2 nidogen/fibulin G2F
- Immunoglobulin-like domain
- Green fluorescent protein
- Growth factor receptor cysteine-rich domain superfamily
- Immunoglobulin I-set
- Immunoglobulin V-set domain
- Immunoglobulin-like fold
- EGF-like calcium-binding, conserved site
- Complement Clr-like EGF domain
- Immunoglobulin-like domain superfamily
- von Willebrand factor A-like domain superfamily
- NOTCH1, EGF-like calcium-binding domain
- Cell Adhesion and Cytoskeletal Organization
- Hemicentin/VWA7, galactose-binding domain-like
- Hemicentin-1-like, von Willebrand factor A domain
- G2F domain
- Calcium-binding EGF domain
- Immunoglobulin I-set domain
- Complement Clr-like EGF-like
- Immunoglobulin domain
- Hemicentin galactose-binding domain-like
- von Willebrand factor A domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads HMCN2 as an antibody target. Whether an autoantibody or antibody against HMCN2 could matter depends on whether native HMCN2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
HMCN2 is annotated as secreted, so native HMCN2 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label HMCN2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...